Pregnancy Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI.
Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI; Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI.
Am J Obstet Gynecol. 2024 Apr;230(4):450.e1-450.e18. doi: 10.1016/j.ajog.2023.10.002. Epub 2023 Oct 6.
Intravascular inflammation and an antiangiogenic state have been implicated in the pathophysiology of preeclampsia. On the basis of the profiles of their angiogenic/antiangiogenic factors, women with preeclampsia at term may be classified into 2 subgroups with different characteristics and prevalence of adverse outcomes. This study was undertaken to examine whether these 2 subgroups of preeclampsia at term also show differences in their profiles of intravascular inflammation.
This study aimed to determine the plasma profiles of cytokines and chemokines in women with preeclampsia at term who had a normal or an abnormal angiogenic profile.
A nested case-control study was conducted to include women classified into 3 groups: women with an uncomplicated pregnancy (n=213) and women with preeclampsia at term with a normal (n=55) or an abnormal (n=41) angiogenic profile. An abnormal angiogenic profile was defined as a plasma ratio of placental growth factor and soluble fms-like tyrosine kinase-1 multiple of the median <10th percentile for gestational age. Concentrations of cytokines were measured by multiplex immunoassays.
Women with preeclampsia at term and an abnormal angiogenic profile showed evidence of the greatest intravascular inflammation among the study groups. These women had higher plasma concentrations of 5 cytokines (interleukin-6, interleukin-8, interleukin-12/interleukin-23p40, interleukin-15, and interleukin-16) and 7 chemokines (eotaxin, eotaxin-3, interferon-γ inducible protein-10, monocyte chemotactic protein-4, macrophage inflammatory protein-1β, macrophage-derived chemokine, and thymus and activation-regulated chemokine compared to women with an uncomplicated pregnancy. By contrast, women with preeclampsia at term and a normal angiogenic profile, compared to women with an uncomplicated pregnancy, had only a higher plasma concentration of monocyte chemotactic protein-4. A correlation between severity of the antiangiogenic state, blood pressure, and plasma concentrations of a subset of cytokines was observed.
Term preeclampsia can be classified into 2 clusters. One is characterized by an antiangiogenic state coupled with an excessive inflammatory process, whereas the other has neither of these features. These findings further support the heterogeneity of preeclampsia at term and may explain the distinct clinical outcomes.
血管内炎症和抗血管生成状态与子痫前期的病理生理学有关。基于其血管生成/抗血管生成因子的特征,足月患有子痫前期的妇女可能分为具有不同特征和不良结局发生率的 2 个亚组。本研究旨在检查这两个足月子痫前期亚组在其血管内炎症特征方面是否存在差异。
本研究旨在确定具有正常或异常血管生成特征的足月子痫前期妇女的血浆细胞因子和趋化因子谱。
进行了嵌套病例对照研究,包括分为 3 组的妇女:无并发症妊娠的妇女(n=213)和足月伴有正常(n=55)或异常(n=41)血管生成特征的子痫前期妇女。异常血管生成特征定义为胎盘生长因子和可溶性 fms 样酪氨酸激酶-1 的血浆比值<妊娠年龄第 10 百分位数的中位数倍数。细胞因子浓度通过多重免疫测定法测量。
具有异常血管生成特征的足月子痫前期妇女在研究组中表现出最大的血管内炎症证据。这些妇女的 5 种细胞因子(白细胞介素 6、白细胞介素 8、白细胞介素 12/白细胞介素 23p40、白细胞介素 15 和白细胞介素 16)和 7 种趋化因子(嗜酸性粒细胞趋化因子、嗜酸性粒细胞趋化因子 3、干扰素-γ诱导蛋白 10、单核细胞趋化蛋白-4、巨噬细胞炎性蛋白-1β、巨噬细胞来源的趋化因子和胸腺激活调节趋化因子)的血浆浓度高于无并发症妊娠的妇女。相比之下,具有正常血管生成特征的足月子痫前期妇女与无并发症妊娠的妇女相比,只有单核细胞趋化蛋白-4 的血浆浓度更高。观察到抗血管生成状态的严重程度、血压和细胞因子亚群的血浆浓度之间存在相关性。
足月子痫前期可分为 2 个亚组。一个特征是抗血管生成状态伴过度炎症过程,另一个则没有这些特征。这些发现进一步支持了足月子痫前期的异质性,并可能解释了不同的临床结局。